Security Snapshot

LifeMD, Inc. - COM (LFMD) Institutional Ownership

CUSIP: 53216B104

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

101

Shares (Excl. Options)

17,835,245

Price

$3.61

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-1,197,540
Value change
-$3,804,703
Number of holders
101
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
SEC-reported price per share
$4.54
Insider filing price
$4.54
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • LFMD - LifeMD, Inc. - COM is tracked under CUSIP 53216B104.
  • 101 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 104 to 101 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $64,617,858 to $64,377,290.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 101 institutions filings for Q1 2026.

Open SEC evidence

Security key

53216B104

Latest holder period

Q1 2026

13F holders

101

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 101 institutional investors reported holding 17,835,245 shares of LifeMD, Inc. - COM (LFMD).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
29
Latest
Q1 2026
Rows shown
1-25 of 29
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 17,835,245 $64,377,290 -$3,804,703 $3.61 101
2025 Q4 18,950,289 $64,617,858 -$11,020,903 $3.41 104
2025 Q3 20,470,274 $138,991,074 -$45,375,687 $6.79 112
2025 Q2 23,936,447 $326,006,450 +$112,379,907 $13.62 126
2025 Q1 16,484,300 $89,676,630 +$3,415,764 $5.44 101
2024 Q4 16,029,161 $79,344,524 -$6,374,196 $4.95 105
2024 Q3 17,035,353 $89,266,499 +$1,809,000 $5.24 98
2024 Q2 16,224,184 $111,297,984 +$5,225,375 $6.86 102
2024 Q1 14,626,097 $150,305,820 +$23,929,069 $10.28 87
2023 Q4 12,444,170 $103,158,574 +$30,594,266 $8.29 84
2023 Q3 8,874,717 $55,469,343 +$20,614,250 $6.25 62
2023 Q2 5,769,940 $25,098,482 +$728,751 $4.35 51
2023 Q1 5,672,748 $9,644,553 -$195,037 $1.70 42
2022 Q4 6,872,731 $13,331,787 +$818,173 $1.94 44
2022 Q3 5,349,277 $10,539,000 -$320,957 $1.97 38
2022 Q2 5,521,717 $11,267,000 +$503,068 $2.04 38
2022 Q1 5,186,481 $18,310,000 -$2,935,896 $3.53 45
2021 Q4 5,968,003 $23,103,000 -$15,438,984 $3.87 52
2021 Q3 8,736,216 $54,234,000 +$9,731,210 $6.21 66
2021 Q2 6,774,639 $79,687,000 +$20,205,923 $11.78 61
2021 Q1 4,720,446 $74,682,000 +$74,590,000 $15.82 46
2020 Q4 7,710 $91,000 $11.80 1
2020 Q3 7,710 $91,000 $11.80 1
2020 Q2 7,710 $91,000 $11.80 1
2020 Q1 7,710 $91,000 $11.80 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .